Pfizer Global Hemophilia Grant – Equity in Therapeutic Patient Education
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Proposals requesting between USD $2,500-$25,000 for 12-18 months will be considered.
Disciplines:
- Health Sciences
Sponsors:
Deadlines:
Internal Deadline:
February 2, 2023Sponsor Deadline:
February 16, 2023Description:
This grant program seeks to champion patient learning and address both educational equity & quality amongst people living with hemophilia (PLwH) to support them in making evidence-informed decisions in a rapidly evolving treatment landscape.
This competitive grant program is open to Patient Advocacy Groups (PAGs) and non-profit organizations – of all sizes and in all countries – that provide education to PLwH. Submissions from applicants in low-, middle-, and high-income countries will be given equal consideration.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.